ViewRay Announces Conference Call for Preliminary First Quarter 2023 Financial Results to be held Pre-Market opening on April 13, 2023

Rhea-AI Summary

ViewRay, Inc. (NASDAQ: VRAY) has scheduled a conference call for April 13, 2023, at 8:00 AM ET to discuss preliminary financial results for the first quarter of 2023. Domestic callers can join at (888) 886-7786 using confirmation number 56031524. A live webcast will also be available on ViewRay's investor relations page. The MRIdian® MR-Guided Radiation Therapy System, designed with high-definition MR imaging, addresses challenges in advanced radiation oncology, such as beam distortion and skin toxicity. This innovative technology differentiates itself from conventional MR systems used in diagnostic radiology.

Positive

• Scheduled conference call indicates proactive communication with shareholders.
• MRIdian therapy system addresses significant clinical challenges, potentially enhancing market position.

Negative

• None.

DENVER, April 12, 2023 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) will hold a conference call to discuss results on Thursday, April 13, 2023, at 8:00 AM ET. The dial-in number for domestic callers is (888) 886-7786. The confirmation number is 56031524. A live webcast of the conference call will be available on the investor relations page of ViewRay's corporate website at https://investors.viewray.com/events-and-webinars.

After the live webcast, a replay will remain available online on the investor relations page of ViewRay's website under "Events and Webinars".

About ViewRay^®

ViewRay, Inc. (Nasdaq: VRAY) designs, manufactures, and markets the MRIdian® MR-Guided Radiation Therapy System. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian's high-definition MR was purpose-built to address specific challenges, including beam distortion, skin toxicity, and other concerns that potentially may arise when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay, Inc.

View original content:https://www.prnewswire.com/news-releases/viewray-announces-conference-call-for-preliminary-first-quarter-2023-financial-results-to-be-held-pre-market-opening-on-april-13-2023-301796074.html

SOURCE ViewRay, Inc.

FAQ

When will ViewRay announce its Q1 2023 financial results?

ViewRay will announce its preliminary first quarter 2023 financial results on April 13, 2023.

What is the purpose of the ViewRay conference call on April 13, 2023?

The conference call will discuss ViewRay's preliminary financial results for the first quarter of 2023.

How can I listen to the ViewRay conference call?

You can listen to the ViewRay conference call by dialing (888) 886-7786 or via the live webcast on ViewRay's investor relations page.